Collectively these results implicate dysregulation of PRKD2 and ITGB4 at the novel loci identified by this study and APOE, NECTIN2 and TOMM40 at the established Chr19q13 AD locus (Fig. S4). Here, TOMM40 is linked to Alzheimer disease.